The question
Does the available information show that compounded BPC-157 is safe and effective for people?
Product and status
On its current safety-risk page, FDA lists BPC-157 in the section for substances that were once in Category 2 and were later withdrawn by their nominators. FDA says compounded drugs containing BPC-157 may pose a risk of immune reactions for some routes. It also notes concerns about peptide impurities and identifying the active ingredient.
FDA says it has little or no safety information for the proposed routes. The agency says it does not have enough information to know whether the drug would harm people. This does not mean that every reported problem was caused by BPC-157.
- Substance: BPC-157
- Context: compounded drugs discussed by FDA
- Common online claims: recovery or tissue repair
Where common claims get ahead of the evidence
Recovery claims often rely on laboratory or animal research, theories about how the substance works, personal stories, or products that are not clearly identified. Those sources do not prove that a human treatment is safe and effective.
A useful human claim would need evidence that matches all of these details:
- The exact formula
- The route
- The people studied
- A meaningful recovery result
- A fair comparison group
- Clear reporting of harmful events
- Enough follow-up time
What remains unknown
- Whether a finished compounded product has the claimed identity, strength, purity, or sterility
- Whether the proposed benefits occur in people
- Which risks may appear with repeated or longer use
- Which groups may face greater risk
- How benefits and harms compare with approved options
Practical takeaway
Treat a recovery promise as unproven unless relevant human evidence supports the exact claim and product. Ask a licensed clinician about approved or better-studied options for the underlying concern.
Sources
These links go to the official pages used for this brief. Source pages and official positions can change, so check them again before relying on a detail.
Educational information only
This brief does not provide medical advice or recommend a product, treatment, dose, source, or protocol. Use it to prepare questions for a licensed professional who knows your history.
To report an error, email hello@peptideliteracylab.com. Include the brief title, the statement, and a supporting source.